Literature DB >> 1835537

A meta-analysis of effects of heparin flush and saline flush: quality and cost implications.

C J Goode1, M Titler, B Rakel, D S Ones, C Kleiber, S Small, P K Triolo.   

Abstract

The purpose of this meta-analysis was to estimate the effects of heparin flush and saline flush solutions on maintaining patency, preventing phlebitis, and increasing duration in peripheral heparin locks. The average effect size (d value) across 15 studies with a total sample size of 3,490 was .0573 for patency (clotting). The 95% credibility interval ranged from -.2267 to .3413. The average effect size across 13 studies with a total sample size of 2,356 was -.0757 for phlebitis. The 95% credibility interval ranged from -.2497 to .0983. The average effect size for duration across six samples with a total sample size of 1,960 was -.0550. The 95% credibility interval ranged from -.2424 to .1324. It can be concluded that saline is as effective as heparin in maintaining patency, preventing phlebitis, and increasing duration in peripheral intravenous locks. Quality of care can be enhanced by using saline as the flush solution, thereby eliminating problems associated with anticoagulant effects and drug incompatibilities. In addition, an estimated yearly savings of $109,100,000 to $218,200,000 U.S. health care dollars could be attained.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835537

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  15 in total

Review 1.  A systematic review of Cochrane anticoagulation reviews.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2009-01-06

2.  Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.

Authors:  A G Randolph; D J Cook; C A Gonzales; M Andrew
Journal:  BMJ       Date:  1998-03-28

Review 3.  Focus on peripherally inserted central catheters in critically ill patients.

Authors:  Paolo Cotogni; Mauro Pittiruti
Journal:  World J Crit Care Med       Date:  2014-11-04

4.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

5.  Heparin is not required for peripheral intravenous locks in neonates.

Authors:  K Brown; J S Tay-Uyboco; D D McMillan
Journal:  Paediatr Child Health       Date:  1999-01       Impact factor: 2.253

Review 6.  Thrombolytic therapy for central venous catheter occlusion.

Authors:  Jacquelyn L Baskin; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Ching-Hon Pui; Scott C Howard
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

7.  Necessity of heparin for maintaining peripheral venous catheters: A systematic review and meta-analysis.

Authors:  Tao You; Jianliang Jiang; Jianchang Chen; Weiting Xu; Li Xiang; Yang Jiao
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

8.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

Review 9.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.

Authors:  Jacquelyn L Baskin; Ching-Hon Pui; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Scott C Howard
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

Review 10.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.